Flagship Harbor Advisors, LLC Ampio Pharmaceuticals, Inc. Transaction History

Flagship Harbor Advisors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 10, 2022	BUY	$0.56 - $1.71 $9,263 - $28,286	16,542 Added 54.41%	46,942 $27,000
Q2 2021 Jul 26, 2021	BUY	$1.56 - $1.98 $1,248 - $1,584	800 Added 2.7%	30,400 $51,000
Q1 2021 May 03, 2021	BUY	$1.36 - $2.49 $10,064 - $18,426	7,400 Added 33.33%	29,600 $50,000
Q4 2020 Feb 08, 2021	BUY	$0.75 - $2.76 $16,650 - $61,271	22,200 New	22,200 $35,000

96.6K

Ticker AMPE
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 226,287,008
Market Cap $2.26M
Description
Ampio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of immunomodulatory therapies for the treatment of pain from osteoarthritis in the United States. Its product pipeline includes AP-013, an intra-articular injection, which is in phase III clinical trial for the treatment of osteoarthritis of the knee; AP-017, an...

Get notified when there are updates to the investment portfolio of Flagship Harbor Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Flagship Harbor Advisors, LLC with notifications on news.